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Insights into the molecular roles of Zika virus in human
reproductive complications and congenital
neuropathologies
RAJENDRA GHARBARAN AND LATCHMAN SOMENARAIN
Department of Biological Sciences, Bronx Community College/The City University of New
York, Bronx, NY
Summary
The recent upsurge in the association of congenital
neurological disorders and infection by the Zika virus
(ZIKV) has resulted in increased research focus on the
biology of this flavivirus. Studies in animal models indicate
that ZIKV can breach the placental barrier and selectively
infect and deplete neuroprogenitor cells (NPCs) of the
developing fetus, resulting in changes of brain structures,
reminiscent of human microcephaly. In vitro and ex vivo
studies using human cells and tissues showed that human
NPCs and placental cells are targeted by ZIKV. Also of
concern is the impact of ZIKV on human reproductive
structures, with the potential to cause infertility, as the virus
appears to remain in the genital tract for extended periods
of time. This review discusses the putative roles of ZIKVon
human reproductive complications and congenital
neuropathologies.
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INTRODUCTION
Zika virus (ZIKV), a positive-strandRNAvirus, is an arbovirus
that belongs to the Flaviviridae family and emerged as a
mosquito-borne virus originally identified in Uganda in 1947.1
Early studies indicated that ZIKV was infectious and patho-
genic to humans,2–4 resulting in headache, malaise, fever,
cutaneous rash, arthralgia, and conjunctivitis in about 20% of
patients and with 80% of infections being asymptomatic.5
Thus, ZIKV was not considered a major public health
concern; however, the recent explosion in ZIKV infection and
its association with severe congenital neurological disorders in
South America (mainly Brazil) in 2015–2016 prompted the
World Health Organization (WHO) to declare the situation as a
Public Health Emergency of International Concern.6 Similar
outbreaks and associated consequences occurred in the Pacific
(specifically the island of Yap) in 20075 and in French Poly-
nesia in 2012–2014.7 The ZIKV-associated neurological dis-
orders mainly include microcephaly in newborns,8
chorioretinopathy in microcephalic infants,9,10 and severe
paralytic neuropathic symptoms of Guillain–Barré syndrome
(GBS) in adults.11–13
Primary microcephaly is a paediatric neurological disorder
characterised by significant reduction in head circumference,
commonly associated with varying degrees of impaired sen-
sory, motor, and cognitive functions.14,15 Primary congenital
microcephaly is caused by decreased neurogenesis in the
brain in utero, resulting from depletion of cortical neural
progenitor cells (NPCs) (a consequence of either apoptosis or
reduced proliferation or a combination of these factors). The
impaired cellular processes that limit neurogenesis in micro-
cephaly arise from deregulated expression of a number of
genes mostly associated with the expression of centrosomal
proteins (reviewed by Tang16 and Barbelanne and Tsang17).
Congenital microcephaly can also arise from infections
caused by Toxoplasma, rubella virus, cytomegalovirus,
herpes virus and the syphilis bacteria (dubbed the TORCHS
factors).18–22
An epidemiological association between ZIKV infection
and microcephaly became obvious during the recent
epidemic, mainly due to the unprecedented increase in infants
born with this devastating neurological disorder.23–26 Despite
warning of an epidemic in February 2015 by WHO, there
were still concerns about whether ZIKV was the cause of the
sudden rise of microcephaly in infants. However, increased
research quickly established ZIKV as a potential teratogenic
agent, resulting from an initial infection. Whilst the principal
mode of ZIKV transmission is by infected Aedes mosquitoes
(Ae. aegypti, Ae. albopictus, Ae. africanus, and Ae. luteoce-
phalus) (reviewed in Hayes),27 other reported means of
transmission include sexual contact,28 the prenatal route from
mother to fetus,29 and through blood transfusion.30 Although
viral particles have been detected in other body fluids such as
saliva,31–33 urine,34 and breastmilk,35 there are no reports
substantiating that ZIKV is spread by these fluids. Evidence
suggests that ZIKV can breach the placental barrier in early
gestation and disrupt neurogenesis, potentially resulting in
severe congenital malformations, as well as giving rise to
intra-uterine growth restriction (IUGR). In addition, emerging
studies indicated that ZIKV could remain in the human genital
tract for months, long after the virus was cleared from other
body fluids,36,37 and in mice ZIKV infection could lead to
severe reproductive pathologies.
This review discusses the putative molecular roles of
ZIKV in human reproductive complication and congenital
neuropathologies.
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ZIKV infection and associated neurological defects have
now been reported for a number of countries in South
America38 and among pregnant travellers to ZIKV-affected
areas.39 Evidence of congenital infection is based on
detection of ZIKV RNA in tissues, amniotic fluid and fetal
brain tissue29,40–42 and anti-ZIKV IgM antibodies in the
cerebrospinal fluid (CSF) of infants born with micro-
cephaly.43 Several studies, including population-based an-
alyses, revealed that there is a greater risk of congenital
microcephaly during the first trimester of pregnancy in
ZIKV-infected mothers.44–46 However, ZIKV infection at
the 36th week (third trimester) of pregnancy can still result
in fetal brain injury, characterised by subependymal cysts
and lenticulostriate vasculopathy in an otherwise normal
sized brain.47 Other clinical aspects associated with ZIKV
infection include brainstem and cerebellar hypoplasia,
delayed myelination/demyelination, severe ventriculome-
galy due to loss of brain tissue, gross calcification of the
brain parenchyma, and some cases of lissencephaly
(absence or reduced neurocortical gyration).48–51 Studies
also reported the prevalence of sensorineural hearing loss in
babies with ZIKV-associated microcephaly.52 In adults, as
stated, ZIKV infection is associated with GBS,11,12 an
autoimmune disease characterised by demyelination of pe-
ripheral motor axons, leading to muscle weakness and pa-
ralysis, and death.11,53 Other flaviviruses are also associated
with GBS.54
CELLULAR MECHANISMS OF ZIKV
TROPISM: RECEPTOR-MEDIATED AND
RECEPTOR-INDEPENDENT
It is now established that ZIKV tropism is mediated by cell
surface receptors DC-SIGN, AXL, heat shock proteins,
TYRO3, and TIM-1.55,56 AXL is a phosphatidylserine pro-
tein that belongs to the TAM receptor family of phagocytic
receptors57 and it appears to play an important role in ZIKV
infection of a wide range of cells of organ systems targeted by
this virus, as discussed below. However, ZIKV may also use
a combination of different cell surface/adhesion molecules to
gain cellular entry.
Some studies have indicated that ZIKV can infect host
cells in the absence of AXL expression. Genetic ablation of
AXL failed to prevent ZIKV infection of NPCs and cerebral
organoid.58 In Axl-/- knockout mice, retinal cells were not
protected against ZIKV infection in vivo and ZIKV RNA
levels in the brains of infected Axl-/- mice were comparable
to that of wild-type animals.59 These studies suggest that cell
surface receptor(s) other than AXL may be needed for ZIKV
attachment to human cells. One such candidate is TYRO3.
Hamel et al. showed that overexpression of TYRO3 in
HEK293 cells, which are normally resistant to this flavivirus,
resulted in ZIKV infection.55 The co-expression of AXL and
TYRO3 by human NPCs60 may explain the extreme sus-
ceptibility of these cells to ZIKV. Therefore, inhibition of
AXL in the presence of TYRO3 can still lead to ZIKV
infection. However, induced pluripotent stem cells (iPSCs)
recalcitrant to ZIKV infection express high levels of TYRO3
(>50 TPM) RNA,58 leading to concerns about the role of this
receptor in viral attachment and cellular entry. Similar con-
cerns may also exist for placental cells targeted by ZIKV,
although more research is needed. However, it is possible that
other unknown or undiscovered receptors mediate cellular
entry of ZIKV.
ZIKV may also invade target cells by receptor-
independent mechanisms, which may be related to
exosomes and extracellular vesicles. Exosomes are cell-
derived, membrane-bound, nano-sized vesicles, used in
cell-cell communication. Exosome-derived cargo, which
may include DNA, RNA, proteins, and lipids, are capable of
influencing cellular responses of target cells. Studies showed
that cells infected by viruses, including the Dengue virus
which is closely related to ZIKV, released exosomes that
shuttled viral RNA and proteins and other genetic elements
and regulatory factors to target cells, effectively spreading
infection.61–64 Several molecular players (syndecan-1,
ALIX, syntenin) involved in exosome biogenesis65,66 are
expressed by subsets of cellular components of the placenta
where they may be involved in immune-modulation.67,68
In vitro studies have shown that trophoblast-derived
exosomes deliver pro-autophagic microRNA (miRNA) to
bystander cells, thereby conferring resistance to viral
infection.69 However, it remains to be determined whether
ZIKV utilises a similar mechanism for viral infection of
cells of placental tissues. In the nervous system, neural stem
cell-derived exosomes significantly enhanced cellular entry
of adenovirus type 5 (Ad5) into Coxsackie virus and
adenovirus receptor (CAR)-deficient cells.70 The uptake of
exosomes may be facilitated by either interaction with the
membrane lipid raft or through mechanisms that do not
involve TAM receptors.
Upon cellular entry, ZIKV triggers the upregulation of
Toll-like receptor 3 (TLR3), RIG-I, and MDA5, and genes
involved in innate immune response as well as several
interferon-stimulated genes, including OAS2, ISG15, and
MX1.55 Most studies have shown that ZIKV limits cell
growth. ZIKV infection of human neuroepithelia stem cells
resulted in translocation of centrosomal and cytosolic protein
pTBK1 (phosphorylated TANK binding kinase 1) to the
mitochondria leading to deregulated mitosis and increased
cell death.60 Increased cell death may also be a result of
ZIKV-induced upregulation of the tumor suppressor gene
TP5371 and of TLR3,72 and suppression of Akt-mTOR,73
which results in autophagy (Fig 1).
PUTATIVE MECHANISM(S) OF ZIKV
SUPPRESSION OF CELLULAR DEFENSES
It has been speculated that once ZIKV infection is fully
established, the virus becomes resistant to interferon treat-
ment, suggesting that the virus develops a set of counter-
measures against the host cell defenses.74 STAT2, which is
the transcriptional activator of interferon responses,75 ap-
pears to be targeted by the ZIKV proteins.76 ZIKV NS5
protein binds to STAT2, leading to proteosomal degradation
of STAT2.74 Also, ZIKV NS1, NS4A, and NS5 proteins
inhibit the induction of type-I IFNs by suppressing IRF3
expression and NF-kB anti-viral signalling.74 The loss of
critical antiviral defense measures (e.g., proteosomal
degradation of STAT2) can contribute to the detriment of
the host cells.
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PUTATIVE MECHANISM(S) OF MOTHER-
FETUS TRANSMISSION
ZIKV-associated disruption of fetal brain growth requires
viral passage across the placental barrier. Placental tropism of
ZIKV is suspected because of the detection of ZIKV particles
and RNA in the placental tissue, amniotic fluid and fetal brain
tissues29,40,77,78 of infected pregnant mothers. However, the
mechanism(s) of mother-to-fetal transmission of ZIKV are
not completely understood. The human placentation displays
unique trophoblast invasion into the maternal decidua basalis
(decidua). Of importance is the establishment of immune-
privileged fetal–maternal interfaces where embryonic and
fetal tissues are in close contact with the mother’s immune
system. The two main interfaces are the decidua that serves as
the anchoring point for the placenta and the intervillous space
where maternal blood is in contact with placental villi.78–80
Placental villi are covered by the superficial multinuclear
syncytiotrophoblast layer (STBs) formed from the fusion of
cells of the inner mononuclear cytotrophoblast layer (CTBs).
At the base of the anchoring villi, proliferative CTBs differ-
entiate into extravillous trophoblasts (EVTs), invade the
decidua and remodel uterine arteries to facilitate blood flow
into the intervillous space.78–80 It has been proposed that
viral infection of placental tissue may occur by direct and
contiguous infection of the cellular layers, virion passage
through a breach, or by cell-mediated transport. Placental-
permissive viruses include rubella, cytomegalovirus, herpes
simplex, HIV-1, hepatitis B and C virus, and parvovirus B19,
avian influenza H5N1, coxsackie virus, and Japanese en-
cephalitis virus,81–84 some of which have been implicated in
congenital neurological defects.85,86 A recent in vitro study
showed that type III interferon IFN-l confers resistance to
trophoblast and non-trophoblast cells to ZIKV exposure,
presumably by autocrine and paracrine modes.87 However, in
humans, considerable placental damage is associated with
ZIKV infection,42 indicating possible viral access to the fetus.
A number of investigators exploited mouse models with
defects in interferon-a/b receptor (IFNAR).88–92 Exposure of
female mice lacking the ability to produce interferon type 1
(IFN)– Ifnar1−/− to ZIKV, resulted in high levels of systemic
ZIKV infection.92 The authors then crossed the Ifnar1−/−with
wild type (WT) to produce heterozygous mice (Ifnar1+/−)
which are supposed to carry functional type I interferon.
However, most of the Ifnar1+/− fetuses, upon exposure to
ZIKV, became infected.92 The ZIKV-infected Ifnar1+/− fe-
tuses died in utero, leaving only placental remnants.92
The remaining intact Ifnar1+/− fetuses showed significant
IUGR.92 In a second model of ZIKV infection during preg-
nancy, WT mice treated with MAR1-5A3 (a blocking anti-
ifnar monoclonal antibody) and inoculated with ZIKV, did
not result in death in utero, although IUGR was detected.92
These studies suggest that high load of ZIKV in immune-
compromised (impaired interferon response) pregnant mice
can lead to mother-to-fetal transmission of this virus. In
addition, co-infection of pregnant C57BL/6 mice with herpes
simplex virus-2 (HSV-2) and ZIKV resulted in enhanced
placental sensitivity to ZIKV, presumably resulting from
increased expression of TAM receptors.93 This study sug-
gests that fetuses of patients with HSV-2 infection may be at
higher risk for the detrimental effects of ZIKV. However,
laboratory tests revealed ZIKV-associated cases in Brazil are
HSV-2 negative.29 Studies on human placental cells and
tissues from various gestational periods revealed potential
damage to this transient organ. ZIKV-infection of placental
explants obtained from first-trimester pregnancy (7–12
weeks of gestation) of healthy women undergoing vaginal
elective termination of pregnancy, with the Brazilian strain of
ZIKV (ZIKVBR), revealed widespread damage to the
maternal decidua, fetal placenta, and umbilical cord.80 The
virus replicated differentially in a wide range of maternal and
fetal cells, including dFibroblasts (decidual fibroblasts), dMf
(decidual macrophages), trophoblasts, and Hofbauer cells,80
suggesting that trans-placental passage of the virus may
occur through succession of adjacent cellular targets from the
decidua basalis to the anchoring villi. A study conducted on a
21-week gestation fetus terminated during pregnancy, to
assess the effects of ZIKV on the placental barrier in vivo,
showed enlarged, hydropic (sign of cellular damage) chori-
onic villi with hyperplasia and focal proliferation of Hofbauer
cells.94
Tabata et al. showed that primary placental cells (cyto-
trophoblasts, endothelial cells, fibroblasts, and Hofbauer cells
in chorionic villi and amniotic epithelial cells and trophoblast
progenitors in amniochorionic membranes) of mid to late
gestation, from 20 healthy humans, were vulnerable to ZIKV
infection, presumably owing to their expression of various
combination of co-factors/receptors that facilitate ZIKV
binding and cellular entry.95 Although this study indicates
that it is possible that late-pregnancy ZIKV infection can lead
to congenital neurological problems because of placental
expression of entry receptors during late gestational stages,
the fetal immune response may be well developed to mini-
mise or prevent neuroinvasion of the brain. In addition, the
fetal brain during late gestation may be advanced enough that
ZIKV infection can inflict harm to only a few neurons and
glial cells, and therefore do not produce severe detrimental
neurological effects. However, late-pregnancy ZIKV-asso-
ciated lesions can still occur via receptor-independent
mechanism(s) as discussed later.
Fig. 1 Putative receptor-mediated ZIKV infections. ZIKV preferentially targets
cells that predominantly express TAM receptors (AXL, Tyro3) and DC-SIGN.
Upon endocytosis, ZIKV (1) triggers translocation of pTBK1 from cytosol to
mitochondria; (2) activates TP53 and TLR3 signalling; (3) activates autophagy
by supression of Akt-mTOR, leading to cell death. ZIKV also induces cell cycle
arrest and reduces cell division (not indicated). These mechanisms are especially
involved in death of NPCs, resulting in cortical defects seen in microcephaly.
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POTENTIAL EFFECTS OF ZIKV ON
REPRODUCTIVE STRUCTURES
There has been a small but growing number of reports on the
presence of ZIKV in body fluids associated with the repro-
ductive system, implying potential for sexual transmission of
the virus and potential for adverse reproductive functions.
Indeed, sexual transmission of ZIKV has been suspected in a
number of cases.96 ZIKV particles and RNA have been
observed in human sperm and in seminal fluid for extended
periods of time, well after it has been cleared from other fluids
such as blood and urine.97 Although spermatozoa lack AXL
expression,55 suggesting potential resistance to cellular entry
by ZIKV, Sertoli cells showed strong expression of this re-
ceptor, which also plays essential roles in mammalian sper-
matogenesis.98,99 Therefore, it has been speculated that the
Sertoli cells might be involved in ZIKV transmission to
spermatozoa,97 perhaps by a mechanism that involves cyto-
plasmic bridges between Sertoli cells and developing sper-
matocytes. Given the cytocidal effects of ZIKV, it is not clear
what the impact of this flavivirus on human spermatozoa and
Sertoli cells might be. However, studies in mice catalogued
widespread damages to male reproductive structures. Sepa-
rate studies using a mouse-adapted African ZIKV strain
(Dakar 41519) and a contemporary ZIKV strain (ZIKA-
SMGC-1) showed viral infection of spermatogonia, primary
spermatocytes, and Sertoli cells, Leydig, and epididymal
epithelial cells, resulting in cell death and destruction of the
seminiferious tubules.100,101 Other associated effects
included reduced levels of testosterone and inhibin B101 and
stimulation of pro-inflammatory cytokines/chemokines pro-
duction and infertility.100,101 In vitro and in vivo studies
showing the effects of ZIKV on human testicular structures
have not been carried out as yet. In addition, it is not clear
whether the immune-privileged nature of human testes will
allow ZIKV to persist in this tissue following cellular inva-
sion by the virus. Should this occur, such a reservoir can
potentially initiate new transmission cycles from seemingly
healthy individuals.102 However, a longitudinal study should
provide greater insights into the impact of ZIKV on human
male reproductive structures. Expected impact in humans
could be male infertility and sterility.
ZIKV may also persist in the female genital tract. Exper-
iments in a murine model of ZIKV infection by intravaginal
deposition of viral particles, demonstrated that ZIKV repli-
cated within the genital mucosa, persisted post-infection, and
was detected in the fetal brain of the mice.103 In humans,
ZIKV has been detected in the genital tract of females and
may remain there for a prolonged period of time,104–106
mirroring reports of the virus in the male genital tract.
However, it is not clear whether ZIKV lodged in the female
vaginal tract can spread to the follicular fluids and potentially
disrupt oocyte viability and embryonic development.
DISRUPTED NEUROCORTICOGENESIS AND
MICROCEPHALY: SELECTIVE ERADICATION
OF NEURONAL PRECURSORS AND
NEUROCORTICAL THINNING
An early study by Bell et al. revealed replication of ZIKV in
neurons and astroglia in the brain of newborn and 5-week old
mice intracerebrally inoculated with the virus,107 indicating
neurovirulence of this flavivirus. A recent study showed the
overexpression of AXL in developing human brain cells,
including radial glia, astrocytes, endothelial cells, and
microglia,108 rendering these cells particularly vulnerable to
ZIKV infection. This vulnerability is reflected in in vivo,
ex vivo, and in vitro studies. The processes of radial glial cells
form tissue scaffold along which neuronal precursors migrate
to the final destination of outer cortical layers. These conse-
quences may partly be a result of ZIKV-induced deregulation
of genes involved in immune response (as indicated above),
cell cycle, and differentiation, and apoptosis of NPCs of
infected embryonic mice.109,110 The ZIKV-associated
cortical malformations are reminiscent of human micro-
cephaly: thinner cortex, reduced gyration, and smaller brain
(Fig 2). In addition, ZIKV infection eradicated NPCs from a
cerebral organoid grown from first-trimester human brain
embryonic stem cells, resulting in restricted growth of the
organoid.72 Reduction in organoid size may be the result of
deregulation of genes involved in neurogenesis, differentia-
tion and apoptosis of ZIKV-infected NPCs.72 Restricted
neurogenesis may also arise from autophagy resulting from
suppression of the Akt-mTOR pathway by ZIKV non-
structural proteins NS4A and NS4B, in viral-infected
human fetal stem cells.73
Studies have shown that some aspects of ZIKV infection of
NPCs mirror molecular, chromosomal, and subcellular
changes that occur in non-ZIKV-associated, inherited ho-
mozygous recessive microcephaly. Underlying genetic
causes of ‘primary’ developmental microcephaly are linked
to defects in centrosomal proteins controlling the mitotic
spindle, thereby assuring normal cell proliferation during
mitosis.111 Disruption of centrosomal proteins may be asso-
ciated with restricted cell growth resulting from ZIKV
infection. Gene expression analyses revealed that genes
(including Microcephalin, CDK5RAP2, CASC5, ASPM,
CENPJ, STIL) mapped to the microcephaly loci were
downregulated to varying degrees in ZIKV-infected fetal
brain samples.112 ZIKV-infected SOX2+ NPCs showed sig-
nificant increase in mitosis abnormalities, including multi-
polar spindle, chromosome laggards, micronuclei and death
Fig. 2 ZIKV infection reduces neurogenesis. In normal neurogenesis, neuronal
precursors migrate along radial glia processes, from the ventricular zone to form
the outer layers of the cerebral cortex, in an inside-out manner. However, ZIKV
infection is likely to eradicate large numbers of radial glia and neuronal pre-
cursors, thereby limiting the number of cortical layers (if any) formed. This
mechanism is suspected to contribute to ZIKV-associated microcephaly.
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of progeny after cell division, and large number of cells with
supernumerary centrosomes.113 Further analyses by fluores-
cent in situ hybridisation (FISH) showed increased fre-
quencies of aneuploidy, such as monosomy, trisomy and
polyploidy on chromosomes 12 and 17.113 Supernumerary
centrosomes, structural disorganisation, and mitotic abnor-
malities in part may be a consequence of sequestration of the
centrosomal and cytosolic protein pTBK1 (phosphorylated
TANK binding kinase 1) to mitochondria as described for
ZIKV-infected human neuroepithelial stem and radial glial
cells.60 In addition, an analysis of predicted epitopes and
human antigens indicated putative peptide sharing between
ZIKV polyprotein and human proteins which are associated
with neuropathologies, including microcephaly and brain
calcification.114 Such proteins include centriolar and centro-
somal components implicated in microcephaly, i.e., C2CD3,
CASC5, CP131, GCP4, KIF2A, STIL, and TBG.114
Disrupted neurogenesis may also be driven by ZIKV-
induced sustained production of proinflammatory cytokines
via paracrine mechanisms. During early development, cranial
or cephalic neural crest cells (CNCCs), which form most of
the cranial bones, exert paracrine effects on the developing
brain. An in vitro study has shown that ZIKV-infected
CNCCs display limited apoptosis but secrete significant
levels of cytokines that can effectively be detrimental to
NPCs.115 This paracrine effect may contribute to the devel-
opment of microcephaly in babies born to ZIKV-infected
mothers, months after birth.
CONGENITAL NEUROLOGICAL DEFECTS OF
LATE STAGE PREGNANCY ZIKV INFECTION
As indicated, late-pregnancy exposure to ZIKV can still
produce congenital neurological deficits. ZIKV infection in
the 36th week of pregnancy resulted in fetuses which showed
preserved head circumference at birth but developed sube-
pendymal cysts and lenticulostriate vasculopathy.47 The
preserved head circumference is consistent with normal cra-
nial growth, which takes place up to 30 weeks. In a separate
case, a mother who reported ZIKV syndrome during third
trimester, presumably after sexual intercourse with her ZIKV-
infected husband, gave birth to a baby with microcephaly.116
The sensitivity of primary placental cells and placental tissue
explants from early to late gestation to ZIKV infection ap-
pears to be consistent with the vulnerability of fetal brain
structures at these stages of gestation. However, the risk for
congenital neurological defects is still greater at early
gestation.
LATE POST-NATAL NEUROLOGICAL
COMPLICATIONS FOLLOWING IN UTERO
ZIKV INFECTION
It has emerged that a subset of babies born to ZIKV preg-
nancies with normal head circumference preserved, showed
severe post-natal brain growth restriction, reminiscent of
microcephaly.117 Neuroimaging showed cortical malforma-
tions predominantly in the anterior brain, and calcifications
predominantly in the subcortical region.117 Some of the in-
fants developed epilepsy, and all had significant motor dis-
abilities.117 However, the CSF for infants investigated was
negative for ZIKV, although ZIKV-specific IgM antibodies
were detected.117
The underlying mechanism that results in post-natal
development of microcephaly is not completely understood.
However, development of cortical malformation typical of
microcephaly may be related to eradication of NPCs and
astroglia (both of which are required to complete neuro-
corticogenesis), persistent inflammation, or residual infection
in neural cells, due to ZIKV infection. Hopefully a large-scale
follow-up study will reveal the extent of the devastating post-
natal impact of ZIKV infection.
ZIKV INVOLVEMENT IN OTHER
NEUROPATHOLOGIES
ZIKV can also infect cells beyond the placenta, reproductive
structures, and the nervous system. In mice, ZIKV infection
was found in the optic nerve, retina, iris, and cornea, and also
triggered panuveitis, conjunctivitis, and neuroretinitis.59 In
humans, ZIKV invasion of ophthalmic tissues is associated
with optic neuritis, chorioretinal atrophy, and blindness in
neonates, and conjunctivitis and uveitis in adults.59,118 In
humans, cells of the outer margin of the neural retina and
cells of the ciliary marginal zone adjacent to neural retina
express AXL,108,119 making these cells susceptible to ZIKV
infection, potentially triggering macular atrophy (leading to
blindness) in babies born to ZIKV-infected mothers. In the
developing human fetus, congenital ocular disease triggered
by ZIKV could be due to the direct invasion of fetal ocular
cells by the virus.
In addition, association of ZIKV and Guillain-Barré syn-
drome, a severe neurological disease characterised by an
immune-mediated progressive muscle weakness that can
result in flaccid paralysis and respiratory failure, has been
noted.12,13,120 Also, a single study revealed that ZIKVmay be
associated with meningeoencephalitis in an adult patient.121
CONCLUSION
It is now evident that ZIKV is a teratogenic agent, resulting in
the increased incidence of primary, congenital microcephaly
and other associated neurodevelopmental disorders. Cells that
are most vulnerable to the destructive effects of ZIKV (prin-
cipally NPCs and astroglia and a subset of placental cells of
early pregnancy) are those that express the presumed cell
surface receptors that facilitate cellular entry of the virus.
Upon infection, ZIKV triggers reduced cellular proliferation
and activates apoptosis and autophagy. These effects may
produce decreased cortical layers in the cerebral cortex. To
access the fetus, ZIKV has to breach the integrity of the
placental barrier. Although the in vitro and in vivo evidence
suggests vulnerability of placental cells to ZIKV, only a subset
of infants born to mothers infected with the virus showed
malformation at birth, while others with normal head
circumference at birth developed microcephaly months after
birth. In addition, the ability of ZIKV to infect AXL-deficient
cells indicates that the virus can exploit other receptors not yet
identified, or a receptor-independent route, for cellular inva-
sion. Hopefully additional research will uncover other re-
ceptors used by ZIKV. Because exosomes and extracellular
vesicles are widely used for intercellular communication, they
may be involved in the spread of ZIKV infection. In addition,
additional large-scale research will be required to assess the
long-term effect of ZIKV on human reproductive organs.
Much remains to be known about the biology of ZIKV.
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